Genospace Expands Board With Appointment of New Advisors

Key leaders at TripAdvisor, Spaulding Rehabilitation Network, and Dartmouth’s Tuck School of Business join advisory board

CAMBRIDGE, MA — July 22, 2015 — Genospace, a provider of cloud-based software solutions for the interpretation and analysis of genomic and other biomedical data, today announced the appointment of three prominent executives to its business advisory board. The following individuals will join current advisor Joseph Donahue, Senior Vice President of Commercial Collaborations and Innovation at BioReference Laboratories, in helping drive the overall growth of Genospace and its mission to serve customers in research, clinical development, pathology and clinical care:

  • Brian Schmidt - Global Vice President, Sales at TripAdvisor
  • Rebecca Kaiser - Chief of Staff at Spaulding Rehabilitation Network
  • Thomas Naughton - Executive Director, Center for Private Equity & Entrepreneurshipand Adjunct Associate Professor at the Tuck School of Business, Dartmouth

As Vice President of Global Sales at TripAdvisor, Brian Schmidt oversees the global sales, operations, analytics, and product teams for TripAdvisor’s core metasearch and Instant Booking businesses.

In her role as Chief of Staff at Spaulding Rehabilitation Network, Rebecca Kaiser is responsible for developing and maintaining community and government relations for Partners Continuing Care (PCC) and overseeing the community and governmental aspects for the Spaulding Network facilities. The Spaulding Network’s facilities are members of Partners HealthCare.

As the Executive Director of the Tuck Center for Private Equity and Entrepreneurship and an Adjunct Associate Professor of Private Equity & Entrepreneurship at the Tuck School of Business, Dartmouth, Thomas Naughton brings his expertise and passion back to his alma mater, as a resource for students, alumni, and practitioners on the inner workings of an economic engine that drives global innovation and productivity. Thomas is also a founder of NeoCarta Ventures, an investor in early-stage IT companies.

"Genospace is proud to bring together such an exceptional group of advisers, each of whom brings valuable talent, experience and judgment," said Daniel Meyer, Chief Operating Officer at Genospace. "We look forward to drawing on this impressive group as we continue to grow and expand our footprint in a rapidly developing market."

About Genospace

At Genospace, we are Digital Architects of Genomic Medicine™. Genospace has built a comprehensive platform for precision medicine to enable interpretation, analysis, reporting and collaboration on high-dimensional genomic and other biomedical data. With specific applications supporting research, development, pathology and clinical care, many of the most advanced precision medicine organizations are powered by Genospace. Visit www.genospace.com for more information.

CONTACT

Daniel Meyer
Genospace
+1-617-520-4182
pr@genospace.com